MCM
STIM icon

Masters Capital Management’s Neuronetics STIM Stock Holding History

Masters Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Hold
1,000,000
– – 0.03% 79
2026
Q1 		$1.45M Hold
1,000,000
– – 0.05% 83
2025
Q4 		$1.38M Hold
1,000,000
– – 0.06% 74
2025
Q3 		$2.73M Hold
1,000,000
– – 0.1% 74
2025
Q2 		$3.49M Hold
1,000,000
– – 0.14% 64
2025
Q1 		$3.68M Sell
1,000,000
-500,000
-33% -$1.83M 0.18% 66
2024
Q4 		$2.42M Buy
1,500,000
+300,000
+25% +$312K 0.09% 74
2024
Q3 		$912K Buy
+1,200,000
New +$1.58M 0.04% 62

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Masters Capital Management's STIM Position: Q2 2026 in Review

Masters Capital Management held its Neuronetics (STIM) position steady in Q2 2026 at 1,000,000 shares worth $1.3M. The position accounts for 0.03% of the portfolio, ranked #79.

Masters Capital Management first reported a position in STIM in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.68M in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Masters Capital Management held 1,000,000 shares of Neuronetics worth $1.3M as of Q2 2026.
  • Masters Capital Management left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up 0.03% of Masters Capital Management's portfolio in Q2 2026, its #79 holding.
  • Masters Capital Management first reported a position in Neuronetics in Q3 2024 and has held it in 8 quarters since.
  • Masters Capital Management's Neuronetics position peaked at $3.68M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Masters Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.